Equity benchmark indices were in the green during early hours on Wednesday with Nifty IT surging by 2.4 per cent. At 10:15 am, the BSE SandP Sensex was up by 175 points or 0.35 per cent at 49,574 while the Nifty 50 surged by 58 points or 0.4 per cent to 14,579. Except for Nifty FMCG and financial service, all sectoral indices at the National Stock Exchange were in the positive zone with Nifty IT advancing by 2.4 per cent, auto by 0.9 per cent and pharma by 0.5 per cent. Among stocks, Wipro was up by 3.1 per cent to Rs 443.60 per share while Tech Mahindra gained by 2.7 per cent, HCL Technologies by 2.2 per cent, Infosys by 2 per cent and Tata Consultancy Services by 1.7 per cent. Tata Motors accelerated by 3.9 per cent to Rs 268.90 per share. HDFC Life, Eicher Motors and Hero MotoCorp too traded with a positive bias. However, Grasim, NTPC, GAIL, UPL, Hindalco, IndusInd Bank and ITC were in losses.
Equity benchmark indices wiped out early losses on Thursday and closed in the positive terrain led by gains in pharma counters. The BSE SandP Sensex closed 92 points or 0.19 per cent higher at 49,584 while the Nifty 50 ticked up by 31 points or 0.21 per cent to 14,596. Sectoral indices at the National Stock Exchange were mixed with Nifty pharma gaining by 0.8 per cent, FMCG by 0.7 per cent and auto by 0.3 per cent. Among stocks, Hindustan Aeronautics surged by 9.5 per cent after the government approved procurement of 83 indigenously developed light combat aircraft Tejas for Indian Air Force at a cost of Rs 48,000 crore. The others which gained marginally included IndianOil Corporation, GAIL, ITC, Britannia and Tata Motors. However, HCL Technologies dropped by 2.3 per cent to Rs 1,031 per share as traders booked profits. Tech Mahindra and Wipro slipped by 1.3 per cent each while Infosys lost by 1.2 per cent. Meanwhile, Japanese stocks jumped to a three-decade high and other Asian equities were near record peaks as investors focused on US stimulus prospects and extended bets on global recovery and growth.
Equity benchmark indices traded lower during early hours on Thursday dragged by technology stocks. At 10:15 am, the BSE S-P Sensex was down by 199 points or 0.4 per cent at 49,293 while the Nifty 50 slipped by 48 points or 0.33 per cent to 14,517.Sectoral indices at the National Stock Exchange were mixed with Nifty IT dipping by 2.1 per cent. Banking and FMCG were in the green. Among stocks, Wipro dropped by 3.7 per cent to Rs 441.65 per share as traders booked profits. HCL Technologies and Infosys fell by 3.2 per cent each, and Tech Mahindra by 2 per cent.
All India Anna Dravida Munnetra Kazhagam (AIADMK) leader VK Sasikala, who was shifted from the Central Jail in Bengaluru to the Lady Curzon Hospital after complaining of fever, is in a stable condition, as informed by her nephew in Bengaluru. "I've reliable info that Sasikala's health is stable, doctors are looking after her. She is being monitored properly. She needs oxygen due to some secondary infections. Doctors still deciding on whether CT scans are required or not," said TTV Dhinakaran, nephew of Sasikala. The 63-year-old leader was a close associate of former Tamil Nadu chief minister, late Jayalalithaa. She has been serving a sentence in a disproportionate assets' case.
A custom official was found with Rs 75 lakh in cash at the Bengaluru airport on January 19. Central Industrial Security Force (CISF) officials intercepted Mohammad Irfan who was travelling to Lucknow along with his wife, and recovered the huge cash from his possession. CISF officials informed the Income Tax Department for further investigation into the matter.
Speaking to ANI in Bengaluru on January 19, president of Karnataka state in Congress, DK Shivakumar said, "We all stand by the farmers of this country. Supreme Court (SC) has stayed the laws. They should scrap it. This is what Congress demands." "The farmers' demand is justified. On behalf of Congress party, we are holding a big protest tomorrow to support them," he added.
Union Health Ministry commented on the deaths post the covid-19 vaccination. Additional secretary said that 3 out of 4 deaths were unrelated to vaccination. In total 7.86 lakh healthcare workers have received Covid-19 vaccine jabs till the evening of the fifth day of the nationwide immunisation drive, as per provisional report of the Union Health Ministry on Jan 20. "The cumulative number of healthcare workers vaccinated against Covid-19 has touched 7,868,42 (till 6 pm Wednesday) through 14,119 sessions, as per the provisional report," the ministry said. On the four deaths reported, one each from Uttar Pradesh and Telangana and two from Karnataka, the official said in case of the death from Moradabad in UP, post mortem confirmed cardio-pulmonary disease and is not related to vaccination. “About the death reported from Bellary in Karnataka, post mortem suggested myocardial infarction and it is not related to vaccination. The other death reported in Shivamoga is also a suspected case of myocardial infarction not related to immunization,” Union Health Ministry Manohar Agnani said. Watch the full video for more.
Credit: HT Digital Content Duration: 01:47Published
Union Health Ministry on January 20 informed that out of four deaths reported after COVID vaccination jab, three are not related to vaccination while post-mortem is underway for one. Additional Secretary of Union Health Ministry, Manohar Agnani said, "Four deaths have been reported from Uttar Pradesh (1), Karnataka (2) and Telangana (1). In Uttar Pradesh, post-mortem confirms cardiopulmonary disease and not related to vaccination. Post-mortem is suggestive of myocardial infarction in case of Karnataka's Bellary and it is also not related to vaccination. The case of Karnataka's Shivamogga is a suspected case of MI and is also not related to vaccination. While in the case of Telangana's Nirmal, post-mortem is undergoing." He also said, "A total of 7,86,842 beneficiaries have been vaccinated till 6 pm today as per the provisional reports. No case of severe/serious AEFI has been attributed to vaccination till date."
Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.